USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 192 filers reported holding USANA HEALTH SCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,881 | -23.1% | 1,107 | -17.3% | 0.00% | 0.0% |
| Q2 2023 | $84,411 | -5.8% | 1,339 | -6.0% | 0.00% | 0.0% |
| Q1 2023 | $89,570 | +164.3% | 1,424 | +123.5% | 0.00% | +100.0% |
| Q4 2022 | $33,888 | +54.0% | 637 | +61.3% | 0.00% | 0.0% |
| Q3 2022 | $22,000 | -4.3% | 395 | +21.9% | 0.00% | 0.0% |
| Q2 2022 | $23,000 | +130.0% | 324 | +149.2% | 0.00% | – |
| Q1 2022 | $10,000 | +233.3% | 130 | +420.0% | 0.00% | – |
| Q4 2021 | $3,000 | +50.0% | 25 | +8.7% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 23 | +21.1% | 0.00% | – |
| Q2 2021 | $2,000 | +100.0% | 19 | +35.7% | 0.00% | – |
| Q1 2021 | $1,000 | – | 14 | +600.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 2 | -92.3% | 0.00% | – |
| Q3 2020 | $2,000 | -33.3% | 26 | -43.5% | 0.00% | – |
| Q2 2020 | $3,000 | +200.0% | 46 | +130.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 20 | -28.6% | 0.00% | – |
| Q2 2019 | $2,000 | – | 28 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DENALI ADVISORS LLC | 50,729 | $3,190,854 | 1.33% |
| Cypress Capital, LLC | 12,227 | $769,078 | 0.25% |
| DGS Capital Management, LLC | 6,835 | $429,922 | 0.24% |
| PZENA INVESTMENT MANAGEMENT LLC | 818,384 | $51,476,354 | 0.22% |
| WINTON GROUP Ltd | 26,950 | $1,695,155 | 0.10% |
| Renaissance Technologies | 1,211,797 | $76,222 | 0.10% |
| Covestor Ltd | 1,602 | $101 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 267,057 | $16,778 | 0.07% |
| Ifrah Financial Services, Inc. | 3,368 | $211,847 | 0.07% |
| CAXTON ASSOCIATES LP | 5,928 | $372,871 | 0.06% |